Delivery Order SPE2DB20D1047-SPE2DB25FF82Y
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Concerta ER 54 mg tablets (100-count units) valued at $9,978.49. This non-set-aside, firm fixed-price contract is scheduled for completion by July 22, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,160.28 to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Concerta ER 54 mg tablets (100 count units). This firm fixed-price delivery order, with an ultimate completion date of September 9, 2025, was competitively awarded without set-aside provisions. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $15,944.96 to AmerisourceBergen Drug Corp for the supply of Concerta ER 36 mg tablets (100-count units) under a firm fixed price contract. The award, issued on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this contract at its corporate office location in the same city. This...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 30, 2025, for the supply of Concerta ER 18 mg tablets (100-count units) with a contract value of $5,679.26. The award is a firm fixed-price delivery order with an ultimate completion date of July 31, 2025, and represents a non-competitive set-aside contract. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Concerta ER 54 mg tablets (100-count units) valued at $10,648.92 under a firm fixed price contract. This is a non-set-aside, competitively awarded delivery order with a completion date of August 6, 2025, and will be performed at the vendor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Concerta ER 36 mg tablets (100-count units) with a ceiling value of $5,573.88. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The contract will be performed in Conshohocken, Pennsylvania, with an ultimate completion date of July 22, 2025. This delivery order is issued as a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $24,854.99 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 27 mg, with an ultimate completion date of July 22, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be performed at the contractor's corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp was awarded a delivery order for Concerta ER 27 mg tablets (100-count units) valued at $3,162.83 under a firm fixed price contract with the Defense Logistics Agency (DLA). The award, issued on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a competitive award with no set-aside designation. Performance will be executed from the contractor's Corporate Office location in Conshohocken, PA. This delivery order is a child contract under...
- The Defense Logistics Agency (DLA) awarded a $3,724.82 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 54 mg on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a single delivery against AmerisourceBergen's larger Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Concerta ER Tabs 36mg, a controlled-release methylphenidate medication used in the treatment of attention deficit hyperactivity disorder. This firm fixed-price delivery order, valued at $33,063.14, represents a non-set-aside competitive award and is scheduled for ultimate completion by August 8, 2025. The contract will be performed at...
- SPE2DB20D1047Indefinite Delivery Contract
- SPE2DB20D1047-SPE2DB25FF82YDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Concerta ER 54 mg tablets (100-count units) valued at $1,199.34, with a firm fixed price arrangement. The contract was awarded on September 10, 2025, with an ultimate completion date of September 11, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The company holds a significant Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling supply of medications and medical commodities to support military healthcare programs worldwide. This delivery order for Concerta ER—a controlled-release methylphenidate medication used for attention deficit hyperactivity disorder treatment—falls within the scope of that broader IDC framework and demonstrates the contractor's capacity to fulfill federal medical supply requirements across diverse therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 9/10/25 |